Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland.
Biosystems and Biomaterials Division, National Institute of Standards and Technology, Gaithersburg, Maryland.
Protein Sci. 2020 Apr;29(4):856-871. doi: 10.1002/pro.3794. Epub 2019 Dec 9.
α -Antitrypsin (α -AT) serves as an archetypal example for the serine proteinase inhibitor (serpin) protein family and has been used as a scaffold for protein engineering for >35 years. Techniques used to engineer α -AT include targeted mutagenesis, protein fusions, phage display, glycoengineering, and consensus protein design. The goals of engineering have also been diverse, ranging from understanding serpin structure-function relationships, to the design of more potent or more specific proteinase inhibitors with potential therapeutic relevance. Here we summarize the history of these protein engineering efforts, describing the techniques applied to engineer α -AT, specific mutants of interest, and providing an appended catalog of the >200 α -AT mutants published to date.
α-1 抗胰蛋白酶(α-1-AT)是丝氨酸蛋白酶抑制剂(serpin)蛋白家族的典型范例,并且已经被用作蛋白质工程的支架超过 35 年。用于工程改造α-1-AT 的技术包括靶向诱变、蛋白融合、噬菌体展示、糖基工程和共识蛋白设计。工程的目标也多种多样,从了解 serpin 结构-功能关系,到设计更有效或更特异的蛋白酶抑制剂,具有潜在的治疗相关性。在这里,我们总结了这些蛋白质工程研究的历史,描述了应用于工程改造α-1-AT 的技术、感兴趣的特定突变体,并提供了迄今为止已发表的超过 200 种α-1-AT 突变体的附录目录。